HIGH EXPRESSION OF BCL-2 PREDICTS POOR OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PATIENTS TREATED WITH CHOP-BASED CHEMOTHERAPY

被引：0
|
作者：
Lee, H. W. [1 ]
Choi, J. -H. [1 ]
Ahn, M. S. [1 ]
Kang, S. Y. [1 ]
Jeong, S. H. [1 ]
Park, J. S. [1 ]
Han, J. H. [2 ]
Kim, J. H. [2 ]
机构：
[1] Ajou Univ Hosp, Dept Hematol Oncol, Suwon, South Korea
[2] Ajou Univ Hosp, Dept Pathol, Suwon, South Korea
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：105 / 106
页数：2
相关论文
共 50 条
  • [21] Low prognostic nutritional index predicts poor outcome in diffuse large B-cell lymphoma treated with R-CHOP
    Qinjun Zhou
    Yongqiang Wei
    Fen Huang
    Xiaolei Wei
    Qi Wei
    Xiaoxiao Hao
    Yuankun Zhang
    Ru Feng
    International Journal of Hematology, 2016, 104 : 485 - 490
  • [22] Beclin 1 expression predicts favorable clinical outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP
    Huang, Jia-Jia
    Zhu, Ying-Jie
    Lin, Tong-Yu
    Jiang, Wen-Qi
    Huang, Hui-Qiang
    Li, Zhi-Ming
    HUMAN PATHOLOGY, 2011, 42 (10) : 1459 - 1466
  • [23] Interstitial lung disease in patients with diffuse large B-cell lymphoma receiving CHOP-based chemotherapy is associated with the use of rituximab
    Go, Ronald S.
    Riggle, Kevin M.
    Beier-Hanratty, Sue A.
    Gundrum, Jacob D.
    Schroeder, Jonean E.
    Wright, Linda J.
    Manske, Brian A.
    BLOOD, 2007, 110 (11) : 1007A - 1007A
  • [24] Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)
    Mounier, N
    Briere, J
    Gisselbrecht, C
    Emile, JF
    Lederlin, P
    Sebban, C
    Berger, F
    Bosly, A
    Morel, P
    Tilly, H
    Bouabdallah, R
    Reyes, F
    Gaulard, P
    Coiffier, B
    BLOOD, 2003, 101 (11) : 4279 - 4284
  • [25] GENE EXPRESSION PROFILING (GEP) AND NOT IMMUNOCHEMICAL ALGORITHMS PREDICTS PROGNOSIS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH R-CHOP
    Gutierrez, G.
    Cardesa, T.
    Climent, F.
    Mate, J.
    Mercadal, S.
    Sancho, J.
    Serrano, S.
    Escoda, L.
    Martinez, A.
    Gine, E.
    Villamor, N.
    Campo, E.
    Colomo, L.
    Lopez-Guillermo, A.
    ANNALS OF ONCOLOGY, 2011, 22 : 108 - 109
  • [26] High Microvascular Density Correlates with Poor Outcome in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab Plus Chemotherapy (R-CT).
    Cardesa-Salzmann, Teresa M.
    Colomo, Luis
    Climent, Fina
    Gonzalez-Barca, Eva
    Lopez-Guillermo, Armando
    Gutierrez, Gonzalo
    Mercadal, Santiago
    Gascoyne, Randy D.
    Connors, Joseph M.
    Rimsza, Lisa M.
    Braziel, Rita M.
    Cook, James R.
    Tubbs, Raymond R.
    Rosenwald, Andreas
    Ott, German
    Luis Mate, Jose
    Ribera, Josep-Maria
    Arenillas, Leonor
    Serrano, Sergi
    Combalia, Neus
    Delabie, Jan
    Lenz, Georg
    Wright, George
    Jaffe, Elaine S.
    Staudt, Louis M.
    Chan, Wing C.
    Weissenburger, Dennis
    Campo, Elias
    BLOOD, 2009, 114 (22) : 772 - 772
  • [27] Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP
    Shustik, Jesse
    Han, Guangming
    Farinha, Pedro
    Johnson, Nathalie A.
    Neriah, Susana Ben
    Connors, Joseph M.
    Sehn, Laurie H.
    Horsman, Douglas E.
    Gascoyne, Randy D.
    Steidl, Christian
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (01): : 96 - 101
  • [28] R-IPI as a predictor of survival in patients with diffuse large cell B-cell lymphoma (DLBCL) treated with R-chop chemotherapy
    Siddiqui, M.
    Johnston, P. B.
    Micallef, I. N.
    Ansell, S. M.
    Colgan, J. P.
    Habermann, T. M.
    Inwards, D. J.
    Markovic, S. N.
    Ristow, K.
    Witzig, T. E.
    Porrata, L. F.
    ANNALS OF ONCOLOGY, 2008, 19 : 146 - 146
  • [29] Low Expression of the CIITA Gene Predicts Poor Outcome in Diffuse Large B-Cell Lymphoma
    Autio, Matias
    Jantti, Kirsi
    Cervera, Alejandra
    Hautaniemi, Sampsa
    Leppa, Sirpa
    BLOOD, 2016, 128 (22)
  • [30] Differences in BCL-2 protein and t(14;18) in patients with primary Rituximab/Chemotherapy refractory diffuse large B-Cell lymphoma (DLBCL)
    Ailawadhi, Sikander
    Hernandez-Ilizaliturri, Francisco J.
    Miner, Loretta
    Bernstein, Zale P.
    Chanan-Khan, Asher
    Miller, Kena C.
    Mohr, Alice
    Starostik, Petr
    Czuczman, Myron S.
    Padmanabhan, Swaminathan
    BLOOD, 2007, 110 (11) : 177B - 177B
12345